- Investing Ideas
- /
- Software Healthcare Sector
Software Healthcare Sector
Results
2252
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2252 companies
Bio-Rad Laboratories
Market Cap: US$8.2b
Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
BIO
US$309.17
7D
14.5%
1Y
-9.3%
Henry Schein
Market Cap: US$8.1b
Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide.
HSIC
US$66.04
7D
-0.02%
1Y
-4.7%
Halozyme Therapeutics
Market Cap: US$8.1b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$66.97
7D
-8.6%
1Y
24.4%
Masimo
Market Cap: US$8.0b
Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.
MASI
US$148.13
7D
3.6%
1Y
9.2%
Guardant Health
Market Cap: US$7.8b
A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
GH
US$63.38
7D
2.2%
1Y
196.9%
HealthEquity
Market Cap: US$7.6b
Provides technology-enabled services platforms to consumers and employers in the United States.
HQY
US$87.78
7D
-7.9%
1Y
6.4%
Waystar Holding
Market Cap: US$7.4b
Develops a cloud-based software solution for healthcare payments.
WAY
US$38.27
7D
2.1%
1Y
38.7%
Merus
Market Cap: US$7.1b
A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.
MRUS
US$94.27
7D
0.6%
1Y
82.6%
Stevanato Group
Market Cap: US$7.1b
Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
STVN
US$24.53
7D
-3.8%
1Y
31.0%
Sonic Healthcare
Market Cap: AU$10.7b
Offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally.
SHL
AU$21.66
7D
1.0%
1Y
-19.4%
Cytokinetics
Market Cap: US$6.8b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$60.64
7D
12.5%
1Y
9.3%
Avidity Biosciences
Market Cap: US$6.8b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$46.18
7D
8.3%
1Y
5.1%
Rhythm Pharmaceuticals
Market Cap: US$6.6b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$97.86
7D
-2.8%
1Y
107.3%
ConvaTec Group
Market Cap: UK£4.8b
Engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.
CTEC
UK£2.38
7D
3.4%
1Y
5.5%
Chemed
Market Cap: US$6.4b
Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.
CHE
US$435.38
7D
-3.7%
1Y
-24.6%
CRISPR Therapeutics
Market Cap: US$6.2b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
CRSP
US$70.19
7D
10.1%
1Y
54.3%
Nuvalent
Market Cap: US$6.1b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$83.85
7D
-1.2%
1Y
-18.9%
Axsome Therapeutics
Market Cap: US$6.0b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$119.94
7D
2.0%
1Y
42.5%
RadNet
Market Cap: US$6.0b
Provides outpatient diagnostic imaging services in the United States and internationally.
RDNT
US$78.29
7D
4.8%
1Y
16.9%
Legend Biotech
Market Cap: US$5.9b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$31.44
7D
-4.3%
1Y
-36.6%
BrightSpring Health Services
Market Cap: US$5.8b
Operates as a home and community-based healthcare services platform in the United States.
BTSG
US$28.87
7D
2.6%
1Y
97.9%
Teleflex
Market Cap: US$5.8b
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
TFX
US$127.71
7D
5.9%
1Y
-45.2%
iRhythm Technologies
Market Cap: US$5.6b
A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
IRTC
US$175.75
7D
3.7%
1Y
191.2%
Bruker
Market Cap: US$5.6b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$36.46
7D
18.1%
1Y
-44.7%
Vaxcyte
Market Cap: US$5.5b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$41.21
7D
18.9%
1Y
-62.0%
Hikma Pharmaceuticals
Market Cap: UK£4.1b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£18.37
7D
10.7%
1Y
-2.2%
Metsera
Market Cap: US$5.5b
A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.
MTSR
US$52.50
7D
0.8%
1Y
n/a
Bausch + Lomb
Market Cap: US$5.4b
Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.
BLCO
US$14.89
7D
-0.5%
1Y
-20.7%
TG Therapeutics
Market Cap: US$5.4b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$36.76
7D
-0.2%
1Y
72.5%
Krystal Biotech
Market Cap: US$5.3b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$180.57
7D
2.2%
1Y
3.2%
PTC Therapeutics
Market Cap: US$5.2b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTCT
US$64.80
7D
6.8%
1Y
85.2%
Alkermes
Market Cap: US$5.1b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$30.99
7D
6.7%
1Y
11.5%
Glaukos
Market Cap: US$5.0b
An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.
GKOS
US$86.62
7D
6.6%
1Y
-31.5%
Arrowhead Pharmaceuticals
Market Cap: US$5.0b
Develops medicines for the treatment of intractable diseases in the United States.
ARWR
US$37.50
7D
11.0%
1Y
106.8%
Merit Medical Systems
Market Cap: US$5.0b
Designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally.
MMSI
US$83.31
7D
3.0%
1Y
-12.0%
Ramsay Health Care
Market Cap: AU$7.3b
Owns and operates hospitals in Australia and internationally.
RHC
AU$31.74
7D
0.03%
1Y
-25.5%